Our Team

Clinicians, educators, and researchers dedicated to ICH care!

Joshua Goldstein

Dr. Joshua Goldstein is an emergency physician who specializes in neurologic emergencies. He is the Director of the Center for Neurologic Emergencies in the Department of Emergency Medicine at Massachusetts General Hospital, and Professor of Emergency Medicine at Harvard Medical School. Dr. Goldstein has participated in, and directed, numerous observational studies and clinical trials of intracerebral hemorrhage and anticoagulation reversal, and has dedicated his career to the critical first hours of ICH. He has worked to write guidelines for organizations such as the Neurocritical Care Society and the American Heart Association.

Qi Li, MD

Dr. Qi Li is the Chief of Neurology at The Second Affiliated Hospital of Anhui Medical University, Hefei, China.  Dr. Li has published extensively on the use of neuroimaging in acute ICH, and how best to use imaging to guide treatment. He has worked at some of the leading ICH research centers worldwide, and now leads a research group in Hefei that performs innovative work on ICH management.

Sasha Yakhkind, MD

Sasha Yakhkind is a neurointensivist at Tufts Medical Center and an assistant professor of neurology and neurosurgery at Tufts University School of Medicine. Her research focuses on cultural perceptions of stroke and provider burnout. She is leading efforts to streamline treatment of ICH based on data compiled by the Code ICH team.


Dr. Stephan Mayer is Director of Neurocritical Care and Emergency Neurology Services for Westchester Medical Center Health System and Professor of Neurology and Neurosurgery at New York Medical College. Dr. Mayer is an international leader in neurocritical care, and was a founding member and past president of the Neurocritical Care Society. He has published extensively on acute management of emergency conditions such as ICH, and led some of the largest clinical trials of procoagulant therapies aimed at reducing ICH expansion.

Anne Alexandrov, PhD
Dr. Anne Alexandrov is a Professor of Nursing and a Professor of Neurology at the University of Tennessee Health Science Center (UTHSC) at Memphis and Chief Nurse Practitioner of the UTHSC Mobile Stroke Unit. Dr. Alexandrov developed and leads the world’s first post-graduate fellowship training program for Advanced Practice Providers (APP) in acute stroke, called the NET SMART (Neurovascular Education & Training in Acute Stroke Management & Reperfusion Therapies) Program (www.learnstroke.com, Health Outcomes Institute, Fountain Hills, Arizona), and graduated over 100 board eligible Advanced Neurovascular Practitioner APPs from across the U.S. and internationally. She is considered the leading international
Dr. Dar Dowlatshahi
Dr. Dar Dowlatshahi is a Professor of Medicine and Epidemiology at the University of Ottawa, a Senior Scientist at the Ottawa Hospital Research Institute and a Stroke Neurologist at the Ottawa Hospital. His research focuses on early hematoma behavior, CT imaging predictors of expansion, and clinical outcomes after ICH. He is active in ICH clinical trials and writing ICH clinical practice guidelines.
W. David Freeman
Dr. Freeman is an internationally renowned expert in neurological and neurosurgical emergencies, acute stroke/cerebrovascular diseases, neurohospital medicine, and neurocritical care given his 3-shield scholarly work in advancing patient care, education, and research. Dr. Freeman’s primary interests are centered around precision medicine of brain-injury and stroke, and in particular hemorrhage stroke, and intraventricular drug discovery, translation, and application. Dr. Freeman was part of the international CLEAR III steering committee and pioneered several innovative brain-injection drug methodologies with global scientific collaborators. Dr. Freeman holds the academic rank of Professor of Neurology and Neurosurgery at Mayo Clinic, and has appointments within the
Jennifer Frontera, MD
Dr. Jennifer Frontera is a neurologist and neurointensivist at NYU-Langone Health. Her research focuses on early brain injury following subarachnoid hemorrhage, long-term, functional outcomes following intracranial hemorrhage, and palliative care for critically-ill patients. She has served on the board of directors of the Neurocritical Care Society and has written extensively on the optimal use of anticoagulant reversal.
Latha Ganti, MD
Dr. Latha Ganti is a Professor of Emergency Medicine and Neurology at the University of Central Florida. She is the Vice Chair for Research & Academic Affairs for the University of Central Florida/HCA Emergency Medicine Residency Program of Greater Orlando, and has published extensively on the crossroads of emergency medicine and vascular neurology. She is the founding Editor in Chief for the International Journal of Emergency Medicine, and has worked extensively with organizations such as the Society for Academic Emegency Medicine and the American Academy of Neurology.
Sayona John
Sayona John, MD, FNCS, FAAN is a professor of neurology and neurocritical care at Rush University Medical Center. . She has served on the board of directors and executive committee of the Neurocritical Care Society.  Her research interest focuses on delirium, encephalopathy and intracranial hemorrhage. As the medical director for the neuroemergency program, she has dedicated her services to the education and management of acute brain injuries.
Casey May
Dr. Casey May is a Clinical Associate Professor at The Ohio State University College of Pharmacy with a clinical appointment at The Ohio State University Wexner Medical Center as a Specialty Practice Pharmacist in the area of Neurocritical Care. She has dedicated her career to neurocritical care pharmacy, and has published extensively on the optimal treatment for acute ICH.
Andrea Morotti
Dr. Andrea Morotti is a Neurologist who specializes in cerebrovascular diseases. He is Assistant Professor of Neurology at the Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili Hospital in Brescia, Italy. His research activity focuses on ICH imaging and predictors of hematoma expansion.
Paul Nyquist MD, MPH
Paul Nyquist MD, MPH, is a full-time tenured professor of neurology, anesthesiology & critical care medicine and neurosurgery at the Johns Hopkins University School of Medicine. He is a clinician and researcher who has gained national and international prominence as part of a community of neurocritical care, intensive care, and cerebrovascular neurologists. He cares for patients who are transported to the Johns Hopkins NCCU from around the world and is a recognized clinical leader in neurocritical care and stroke. He also has a unique expertise in military operational medicine and diving medicine and was trained as an undersea medical
Adrian Parry-Jones
Adrian Parry-Jones is a Stroke Association Reader at the University of Manchester and an Honorary Consultant Neurologist at Salford Royal Hospital in the UK. His current research and clinical work is focused on improving outcomes after intracerebral haemorrhage. He developed and implemented the ABC care bundle for intracerebral haemorrhage, that reduced deaths at Salford by a third and is now being implemented across the North of England.
Octavio M Pontes-Neto
Octavio M Pontes-Neto is Neurologist and head of the service of Vascular Neurology and Neurological Emergencies of the Hospital das Clinicas de Ribeirão Preto. He is the former President and current Vice-president of the Brazilian Stroke Society. He currently works as an Associate Professor of Neurology at the Ribeirão Preto Medical School, University of São Paulo. He is the Chair of the Brazilian Stroke Research Network. He is also the co-chair of the World Stroke Organization Education Committee.
Jonathan Rosand
Jonathan is Professor of Neurology at Harvard and Associate Member of the Broad Institute. At Mass General, he holds the J.P. Kistler Endowed Chair in Neurology, and serves as Managing Co-Director of the McCance Center for Brain Health and former Chief of Neurocritical Care. An internationally renowned scientist, clinician, educator, mentor and visionary leader, Dr Rosand has created a legacy of multidisciplinary teams that are successfully tackling some of the most pressing challenges in brain disease. His research program, launched over 20 years ago, has been a world leader in the study of ICH and in high-throughput genetic studies
Kevin Sheth, MD
Dr. Kevin Sheth is the Vice Chair for Clinical & Translational Research in Neurology & Neurosurgery and founding Chief of the Division of Neurocritical Care & Emergency Neurology at Yale-New Haven Hospital. He has led and developed highly innovative programs in drug development and translation for stroke and ICH. His research has been funded by the NIH, American Academy of Neurology, AHA, and the US Army. He is an Associate Editor at Stroke and a member of the American Neurological Association Board of Directors. He currently leads multiple initiatives at the American Heart Association aimed at improving ICH care
Kori Zachrison
Dr. Kori Sauser Zachrison is an Associate Professor of Emergency Medicine at Harvard Medical School and the MGH Trustees Endowed Scholar in Emergency Medicine Research at the Massachusetts General Hospital Department of Emergency Medicine. Dr. Zachrison’s research focuses on improving systems of care for time-sensitive emergency care delivery. She has been continuously funded as principal and co-investigator on grants including from the Agency for Healthcare Research and Quality, the National Institute of Neurological Disorders and Stroke, the American Heart Association, and the Emergency Medicine Foundation. Dr. Zachrison has also been committed to improving the quality of stroke and ICH

Join Us

Interested in joining our team? Please email jgoldstein@mgh.harvard.edu.

Do you represent a hospital or clinical provider?

Click here and join our team and registry!


Interested in supporting our efforts?

Click here to donate to our cause!